Document is current
Any future updates will be listed below
-
Authors
Liu, Xuejing
He, Anyuan
Lu, Dongliang
Hu, Donghua
Tan, Min
Abere, Abenezer
Goodarzi, Parniyan
Ahmad, Bilal https://orcid.org/0000-0002-5848-4349
Kleiboeker, Brian https://orcid.org/0000-0002-3196-1803
Finck, Brian N. https://orcid.org/0000-0001-5411-3674
Zayed, Mohamed https://orcid.org/0000-0001-6443-4527
Funai, Katsuhiko
Brestoff, Jonathan R. https://orcid.org/0000-0002-7018-7400
Javaheri, Ali
Weisensee, Patricia https://orcid.org/0000-0003-0283-9347
Mittendorfer, Bettina
Hsu, Fong-Fu
Van Veldhoven, Paul P.
Razani, Babak https://orcid.org/0000-0002-7172-9240
Semenkovich, Clay F. https://orcid.org/0000-0003-1163-1871
Lodhi, Irfan J. https://orcid.org/0000-0002-6246-9862
- License Information
-
More Information
Article History
Received: 12 February 2024
Accepted: 12 August 2025
First Online: 17 September 2025
Competing interests
: I.J.L. and X.L. are named on a provisional patent application (serial no. 63/872,889) filed by Washington University related to targeting ACOX2 activation as a treatment for obesity and related metabolic diseases. The other authors declare no competing interests.
